Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Salix Pharmaceuticals (SLXP): Q1 EPS of $0.67 beats by $0.11. Revenue of $171.1M (+62% Y/Y). (PR)

  • Monday, May 7, 2012, 5:16 PM ET
    Salix Pharmaceuticals (SLXP): Q1 EPS of $0.67 beats by $0.11. Revenue of $171.1M (+62% Y/Y). (PR)
Other date
DJIA (DIA) S&P 500 (SPY)